ARTERIS INC

Hawkins Nicholas B.’s recent Arteris shares sale shows modest insider activity, suggesting routine portfolio tweaks rather than a crisis.

Inside look at Raza Saiyed Atiq’s disciplined 10‑b‑5‑1 sales of ARTERIS shares amid a 14.8% weekly jump—what it means for investors and the high‑growth chip firm.

Arteris insider selling spikes, but CEO’s disciplined plan signals routine liquidity, not trouble—investors can still expect growth.

Arteris insider sales show CEO’s disciplined 10(b)(5) strategy—planned, not panic—hinting at confidence in the company’s IP value and future upside.

Arteris insider sales: COO Moll Laurent’s recent 39k‑share dump amid a 25% rally shows strategic exposure management, not panic, but urges investors to re‑evaluate risk‑return in this high‑growth semiconductor niche.

Arteris insider sale of 20,839 shares by Viana Antonio J highlights routine portfolio rebalancing, not loss of confidence, amid board buying and strong IP‑licensing growth.

Arteris insider sales reveal tactical trading, not a strategic sell‑off—yet strong fundamentals and IP growth keep investors hopeful for future gains.

Arteris CEO sells 50,000 shares amid rising stock—insider trades signal portfolio balancing, not a loss of confidence.

Arteris CFO’s mixed buy‑sell moves reveal a cautious but bullish stance on the company’s NoC IP future – a key insider signal for investors.

Arteris insider selling continues—Viana Family Trust’s 10‑b‑1 plan, exec tranches, and social‑media buzz show a disciplined liquidity strategy amid strong earnings.